Mir A. Imran, Director, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), bought 36,000 shares at $0.69 ($25K) on 2026-07-21, disclosed to the SEC on 2026-07-23.
Open-market purchase of $25k RANI by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |